Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Feeding and Eating Disorders | 38 | 2022 | 106 | 11.250 |
Why?
|
| Stress Disorders, Post-Traumatic | 22 | 2022 | 1506 | 5.240 |
Why?
|
| Anorexia Nervosa | 22 | 2020 | 52 | 3.230 |
Why?
|
| Bulimia | 35 | 2020 | 72 | 2.610 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 4 | 2022 | 19 | 2.280 |
Why?
|
| Bulimia Nervosa | 7 | 2020 | 21 | 2.210 |
Why?
|
| Binge-Eating Disorder | 6 | 2021 | 16 | 1.810 |
Why?
|
| Depressive Disorder, Major | 6 | 2022 | 438 | 1.490 |
Why?
|
| Seasons | 12 | 2018 | 129 | 1.450 |
Why?
|
| Food Addiction | 2 | 2020 | 3 | 1.380 |
Why?
|
| Crime Victims | 5 | 2020 | 286 | 1.250 |
Why?
|
| Antipsychotic Agents | 6 | 2017 | 247 | 1.220 |
Why?
|
| Serotonin | 17 | 2012 | 144 | 1.210 |
Why?
|
| Residential Treatment | 4 | 2022 | 24 | 1.200 |
Why?
|
| Psychotherapy | 7 | 2022 | 253 | 1.170 |
Why?
|
| Comorbidity | 19 | 2022 | 1425 | 1.060 |
Why?
|
| Behavior, Addictive | 3 | 2016 | 317 | 1.000 |
Why?
|
| Adult | 61 | 2022 | 21375 | 0.960 |
Why?
|
| Humans | 100 | 2022 | 68525 | 0.960 |
Why?
|
| Feeding Behavior | 5 | 2020 | 224 | 0.920 |
Why?
|
| Female | 71 | 2022 | 38015 | 0.890 |
Why?
|
| Substance-Related Disorders | 9 | 2022 | 1241 | 0.840 |
Why?
|
| Child Abuse | 2 | 2021 | 186 | 0.820 |
Why?
|
| Compulsive Behavior | 3 | 2016 | 12 | 0.810 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 37 | 0.770 |
Why?
|
| Quality of Life | 4 | 2022 | 1515 | 0.770 |
Why?
|
| Hydroxyindoleacetic Acid | 4 | 2018 | 36 | 0.760 |
Why?
|
| Benzodiazepines | 3 | 2017 | 130 | 0.750 |
Why?
|
| Homovanillic Acid | 3 | 2018 | 52 | 0.750 |
Why?
|
| Adolescent | 22 | 2022 | 8903 | 0.730 |
Why?
|
| Sensation | 1 | 2018 | 49 | 0.650 |
Why?
|
| Vomiting | 3 | 2016 | 56 | 0.640 |
Why?
|
| Weather | 1 | 2018 | 9 | 0.640 |
Why?
|
| Migraine Disorders | 7 | 2016 | 66 | 0.640 |
Why?
|
| Mental Disorders | 6 | 2017 | 659 | 0.630 |
Why?
|
| Appetite Regulation | 1 | 2017 | 11 | 0.630 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 79 | 0.620 |
Why?
|
| Weight Gain | 2 | 2017 | 135 | 0.620 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 189 | 0.610 |
Why?
|
| Diet | 2 | 2020 | 513 | 0.610 |
Why?
|
| Depressive Disorder | 14 | 2000 | 621 | 0.590 |
Why?
|
| Alcoholism | 3 | 2022 | 1109 | 0.570 |
Why?
|
| Psilocybin | 1 | 2016 | 1 | 0.570 |
Why?
|
| Male | 39 | 2022 | 37281 | 0.560 |
Why?
|
| Psychotropic Drugs | 1 | 2016 | 83 | 0.540 |
Why?
|
| Combined Modality Therapy | 5 | 2022 | 951 | 0.520 |
Why?
|
| Cannabinoids | 1 | 2016 | 90 | 0.520 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 172 | 0.510 |
Why?
|
| Young Adult | 9 | 2020 | 5708 | 0.490 |
Why?
|
| Child Abuse, Sexual | 3 | 2021 | 150 | 0.490 |
Why?
|
| Exercise | 2 | 2016 | 657 | 0.460 |
Why?
|
| Marijuana Abuse | 2 | 2016 | 251 | 0.450 |
Why?
|
| Clozapine | 4 | 1998 | 46 | 0.450 |
Why?
|
| Risk Factors | 10 | 2020 | 5719 | 0.440 |
Why?
|
| Receptors, Serotonin | 6 | 2004 | 74 | 0.430 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 102 | 0.420 |
Why?
|
| Carbonated Beverages | 1 | 2011 | 9 | 0.410 |
Why?
|
| Fast Foods | 1 | 2011 | 8 | 0.410 |
Why?
|
| Piperazines | 5 | 1996 | 206 | 0.410 |
Why?
|
| Thinness | 1 | 2011 | 14 | 0.400 |
Why?
|
| Surveys and Questionnaires | 11 | 2018 | 2798 | 0.400 |
Why?
|
| Analysis of Variance | 7 | 2016 | 1039 | 0.400 |
Why?
|
| Psychiatric Status Rating Scales | 15 | 2015 | 782 | 0.390 |
Why?
|
| Weight Loss | 3 | 2011 | 319 | 0.390 |
Why?
|
| Child | 10 | 2022 | 6400 | 0.380 |
Why?
|
| Tryptophan | 7 | 1996 | 65 | 0.380 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 1996 | 88 | 0.350 |
Why?
|
| Fluoxetine | 4 | 1992 | 40 | 0.340 |
Why?
|
| Prevalence | 10 | 2016 | 1609 | 0.320 |
Why?
|
| Psychotic Disorders | 3 | 1997 | 157 | 0.300 |
Why?
|
| Serotonin Receptor Agonists | 2 | 1996 | 34 | 0.260 |
Why?
|
| Dissociative Disorders | 3 | 2022 | 16 | 0.260 |
Why?
|
| Body Image | 7 | 2011 | 100 | 0.260 |
Why?
|
| Obesity | 3 | 2021 | 1074 | 0.250 |
Why?
|
| Hydrocortisone | 5 | 2000 | 291 | 0.240 |
Why?
|
| Middle Aged | 15 | 2018 | 21119 | 0.240 |
Why?
|
| Eating | 5 | 2016 | 119 | 0.230 |
Why?
|
| Diagnosis, Differential | 6 | 2016 | 1139 | 0.230 |
Why?
|
| Treatment Outcome | 6 | 2022 | 7028 | 0.230 |
Why?
|
| Carbamazepine | 3 | 1997 | 108 | 0.230 |
Why?
|
| Prolactin | 5 | 2000 | 61 | 0.230 |
Why?
|
| United States | 6 | 2021 | 7335 | 0.230 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2016 | 929 | 0.220 |
Why?
|
| Double-Blind Method | 4 | 2022 | 1737 | 0.220 |
Why?
|
| Patient Acuity | 1 | 2022 | 17 | 0.210 |
Why?
|
| Headache | 1 | 2022 | 68 | 0.210 |
Why?
|
| Sex Factors | 6 | 2018 | 1265 | 0.210 |
Why?
|
| Heterosexuality | 1 | 2021 | 16 | 0.200 |
Why?
|
| Personality Inventory | 5 | 2011 | 196 | 0.200 |
Why?
|
| Suicide | 3 | 2000 | 115 | 0.200 |
Why?
|
| Hyperphagia | 1 | 2000 | 7 | 0.200 |
Why?
|
| Leptin | 2 | 2000 | 80 | 0.190 |
Why?
|
| Syndrome | 2 | 2016 | 255 | 0.190 |
Why?
|
| Diet, Reducing | 1 | 2000 | 46 | 0.190 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2017 | 257 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2011 | 866 | 0.190 |
Why?
|
| Personality | 2 | 2011 | 66 | 0.190 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 2018 | 41 | 0.190 |
Why?
|
| Brain | 6 | 2004 | 2175 | 0.190 |
Why?
|
| Dopamine | 3 | 2012 | 474 | 0.180 |
Why?
|
| Anxiety | 3 | 2020 | 422 | 0.180 |
Why?
|
| Sex Offenses | 2 | 2021 | 170 | 0.180 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 1851 | 0.170 |
Why?
|
| Pirenzepine | 1 | 1998 | 17 | 0.170 |
Why?
|
| Serotonin Antagonists | 1 | 1998 | 31 | 0.170 |
Why?
|
| Risperidone | 1 | 1998 | 48 | 0.170 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 71 | 0.160 |
Why?
|
| Crack Cocaine | 1 | 1998 | 20 | 0.160 |
Why?
|
| Hallucinations | 2 | 1996 | 19 | 0.160 |
Why?
|
| Arousal | 4 | 1995 | 168 | 0.160 |
Why?
|
| Schizophrenia | 3 | 1996 | 206 | 0.160 |
Why?
|
| Body Weight | 7 | 2000 | 554 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 2264 | 0.150 |
Why?
|
| Age of Onset | 2 | 2014 | 188 | 0.150 |
Why?
|
| Social Environment | 1 | 1998 | 182 | 0.140 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1996 | 20 | 0.140 |
Why?
|
| Psychopharmacology | 1 | 2016 | 2 | 0.140 |
Why?
|
| Leisure Activities | 1 | 2016 | 22 | 0.140 |
Why?
|
| Stuttering | 1 | 1996 | 2 | 0.140 |
Why?
|
| Health Behavior | 1 | 2020 | 458 | 0.140 |
Why?
|
| Cataplexy | 1 | 1996 | 25 | 0.140 |
Why?
|
| 1-Naphthylamine | 1 | 1996 | 11 | 0.140 |
Why?
|
| China | 1 | 2016 | 138 | 0.140 |
Why?
|
| Athletes | 1 | 2016 | 40 | 0.140 |
Why?
|
| Logistic Models | 2 | 2017 | 1419 | 0.140 |
Why?
|
| Family | 1 | 1998 | 293 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1548 | 0.140 |
Why?
|
| Bipolar Disorder | 4 | 1994 | 307 | 0.140 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 96 | 0.130 |
Why?
|
| Isatin | 1 | 1995 | 3 | 0.130 |
Why?
|
| Seizures | 2 | 1997 | 279 | 0.130 |
Why?
|
| Phobic Disorders | 2 | 1995 | 227 | 0.130 |
Why?
|
| Reference Values | 6 | 2000 | 579 | 0.130 |
Why?
|
| Delirium | 1 | 1995 | 45 | 0.130 |
Why?
|
| Lithium | 2 | 1986 | 76 | 0.130 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1996 | 91 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2022 | 3185 | 0.130 |
Why?
|
| Demeclocycline | 1 | 1994 | 2 | 0.130 |
Why?
|
| Delusions | 1 | 1994 | 20 | 0.120 |
Why?
|
| Parturition | 2 | 2011 | 15 | 0.120 |
Why?
|
| Hyponatremia | 1 | 1994 | 20 | 0.120 |
Why?
|
| Religion | 1 | 1994 | 23 | 0.120 |
Why?
|
| Pyridines | 1 | 1996 | 261 | 0.120 |
Why?
|
| Self Concept | 2 | 2011 | 132 | 0.120 |
Why?
|
| Dextromethorphan | 1 | 1993 | 5 | 0.120 |
Why?
|
| Motivation | 1 | 1998 | 561 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2015 | 392 | 0.120 |
Why?
|
| Nonprescription Drugs | 1 | 1993 | 28 | 0.120 |
Why?
|
| Linear Models | 2 | 2015 | 521 | 0.120 |
Why?
|
| Drug Therapy, Combination | 6 | 1996 | 648 | 0.120 |
Why?
|
| beta-Endorphin | 1 | 1992 | 15 | 0.110 |
Why?
|
| Cocaine-Related Disorders | 1 | 1998 | 504 | 0.110 |
Why?
|
| Dynorphins | 1 | 1992 | 69 | 0.110 |
Why?
|
| Drinking | 1 | 1992 | 35 | 0.110 |
Why?
|
| Blood Platelets | 1 | 1993 | 284 | 0.100 |
Why?
|
| Synaptic Transmission | 2 | 2012 | 236 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2017 | 7264 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 124 | 0.100 |
Why?
|
| Time | 1 | 2011 | 57 | 0.100 |
Why?
|
| Dogs | 1 | 1992 | 490 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2011 | 424 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 1992 | 470 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2021 | 150 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 378 | 0.080 |
Why?
|
| Age Factors | 5 | 2010 | 1860 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 3256 | 0.080 |
Why?
|
| Dexamethasone | 2 | 1987 | 150 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2012 | 3702 | 0.080 |
Why?
|
| Interview, Psychological | 1 | 2007 | 113 | 0.070 |
Why?
|
| Aged | 4 | 2016 | 14842 | 0.070 |
Why?
|
| Leukopenia | 1 | 1986 | 23 | 0.070 |
Why?
|
| Appetite | 4 | 1998 | 16 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1996 | 1745 | 0.070 |
Why?
|
| Mood Disorders | 1 | 1986 | 132 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 848 | 0.060 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 51 | 0.060 |
Why?
|
| Italy | 1 | 2004 | 36 | 0.060 |
Why?
|
| Culture | 1 | 2004 | 75 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 81 | 0.060 |
Why?
|
| Florida | 1 | 2004 | 221 | 0.060 |
Why?
|
| Environment | 1 | 2004 | 115 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 137 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 1998 | 546 | 0.060 |
Why?
|
| Schizophrenic Psychology | 2 | 1994 | 53 | 0.060 |
Why?
|
| Fear | 1 | 2004 | 239 | 0.060 |
Why?
|
| Norepinephrine | 3 | 1993 | 276 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 290 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 614 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2004 | 296 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 370 | 0.050 |
Why?
|
| Anxiety Disorders | 3 | 2000 | 426 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 138 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2000 | 80 | 0.050 |
Why?
|
| Research | 1 | 2002 | 214 | 0.050 |
Why?
|
| South Carolina | 3 | 1998 | 2750 | 0.050 |
Why?
|
| Psychopathology | 1 | 2017 | 29 | 0.040 |
Why?
|
| Amino Acids | 3 | 1988 | 131 | 0.040 |
Why?
|
| Research Design | 2 | 1992 | 729 | 0.040 |
Why?
|
| Sex Distribution | 1 | 1998 | 272 | 0.040 |
Why?
|
| Consciousness | 1 | 1997 | 17 | 0.040 |
Why?
|
| Satiety Response | 2 | 1995 | 8 | 0.040 |
Why?
|
| Fluvoxamine | 1 | 1996 | 22 | 0.040 |
Why?
|
| Alcohol-Related Disorders | 1 | 1998 | 95 | 0.040 |
Why?
|
| Personality Disorders | 1 | 1997 | 43 | 0.040 |
Why?
|
| Prognosis | 1 | 2002 | 2093 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 1996 | 26 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 1996 | 29 | 0.040 |
Why?
|
| Nutritional Status | 1 | 1997 | 112 | 0.040 |
Why?
|
| Hunger | 1 | 1996 | 27 | 0.030 |
Why?
|
| Sertraline | 1 | 1996 | 62 | 0.030 |
Why?
|
| Endorphins | 2 | 1992 | 32 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 772 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 1997 | 223 | 0.030 |
Why?
|
| Internal-External Control | 1 | 1995 | 60 | 0.030 |
Why?
|
| Fasting | 1 | 1995 | 75 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1995 | 289 | 0.030 |
Why?
|
| Superstitions | 1 | 1994 | 1 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1995 | 78 | 0.030 |
Why?
|
| Michigan | 1 | 1994 | 68 | 0.030 |
Why?
|
| Neural Pathways | 1 | 1996 | 323 | 0.030 |
Why?
|
| Life Change Events | 1 | 1995 | 223 | 0.030 |
Why?
|
| Drug and Narcotic Control | 1 | 1993 | 15 | 0.030 |
Why?
|
| Sodium | 1 | 1994 | 161 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 1997 | 342 | 0.030 |
Why?
|
| Sincalide | 1 | 1993 | 12 | 0.030 |
Why?
|
| Medical Records | 1 | 1994 | 121 | 0.030 |
Why?
|
| Health Surveys | 2 | 2011 | 488 | 0.030 |
Why?
|
| Proteins | 1 | 1997 | 473 | 0.030 |
Why?
|
| Affective Symptoms | 1 | 1993 | 50 | 0.030 |
Why?
|
| Thiothixene | 1 | 1992 | 1 | 0.030 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1992 | 21 | 0.030 |
Why?
|
| Drug Overdose | 1 | 1993 | 67 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1993 | 304 | 0.030 |
Why?
|
| Placebos | 1 | 1992 | 195 | 0.030 |
Why?
|
| Synapses | 1 | 1995 | 222 | 0.030 |
Why?
|
| Satiation | 1 | 1992 | 9 | 0.030 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1991 | 45 | 0.030 |
Why?
|
| Sleep | 1 | 1994 | 263 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 1993 | 209 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 1992 | 218 | 0.030 |
Why?
|
| Estradiol | 1 | 1992 | 176 | 0.030 |
Why?
|
| Hand | 1 | 1992 | 90 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 1993 | 339 | 0.020 |
Why?
|
| Seasonal Affective Disorder | 1 | 1991 | 2 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1991 | 219 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 567 | 0.020 |
Why?
|
| Acute Disease | 1 | 1992 | 658 | 0.020 |
Why?
|
| Women | 1 | 2011 | 40 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1990 | 68 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1990 | 163 | 0.020 |
Why?
|
| Fenfluramine | 1 | 1990 | 6 | 0.020 |
Why?
|
| Recurrence | 1 | 1992 | 948 | 0.020 |
Why?
|
| Hospitalization | 1 | 1994 | 977 | 0.020 |
Why?
|
| Drug Monitoring | 2 | 2000 | 107 | 0.020 |
Why?
|
| Depression | 1 | 1995 | 942 | 0.020 |
Why?
|
| Lactates | 1 | 1987 | 29 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 1993 | 805 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1986 | 94 | 0.020 |
Why?
|
| Haloperidol | 1 | 1986 | 95 | 0.020 |
Why?
|
| Time Factors | 1 | 1994 | 4655 | 0.020 |
Why?
|
| Animals | 2 | 1993 | 20877 | 0.020 |
Why?
|
| Lithium Carbonate | 1 | 1983 | 31 | 0.010 |
Why?
|
| Personality Assessment | 2 | 1993 | 71 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1983 | 260 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 4843 | 0.010 |
Why?
|
| Research Personnel | 1 | 2000 | 83 | 0.010 |
Why?
|
| Physician's Role | 1 | 2000 | 116 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2000 | 172 | 0.010 |
Why?
|
| Anorexia | 1 | 1997 | 7 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 442 | 0.010 |
Why?
|
| Mass Screening | 1 | 2000 | 837 | 0.010 |
Why?
|
| Vascular Headaches | 1 | 1993 | 1 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1991 | 30 | 0.010 |
Why?
|
| Self Mutilation | 1 | 1990 | 2 | 0.010 |
Why?
|
| Pulse | 1 | 1990 | 23 | 0.010 |
Why?
|
| Suicide, Attempted | 1 | 1990 | 72 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1990 | 223 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 334 | 0.010 |
Why?
|
| Social Behavior | 1 | 1991 | 164 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1993 | 1341 | 0.010 |
Why?
|
| Incidence | 1 | 1993 | 1582 | 0.010 |
Why?
|
| Psychometrics | 1 | 1991 | 514 | 0.000 |
Why?
|
| Panic | 1 | 1987 | 97 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1987 | 86 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1990 | 1447 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1984 | 737 | 0.000 |
Why?
|
| Models, Biological | 1 | 1984 | 981 | 0.000 |
Why?
|